Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT

• Príomhchruthaitheoirí: Peter J Selby (Údar), Rosamonde E Banks (Údar), Walter Gregory (Údar), Jenny Hewison (Údar), William Rosenberg (Údar), Douglas G Altman (Údar), Jonathan J Deeks (Údar), Christopher McCabe (Údar), Julie Parkes (Údar), Catharine Sturgeon (Údar), Douglas Thompson (Údar), Maureen Twiddy (Údar), Janine Bestall (Údar), Joan Bedlington (Údar), Tilly Hale (Údar), Jacqueline Dinnes (Údar), Marc Jones (Údar), Andrew Lewington (Údar), Michael P Messenger (Údar), Vicky Napp (Údar), Alice Sitch (Údar), Sudeep Tanwar (Údar), Naveen S Vasudev (Údar), Paul Baxter (Údar), Sue Bell (Údar), David A Cairns (Údar), Nicola Calder (Údar), Neil Corrigan (Údar), Francesco Del Galdo (Údar), Peter Heudtlass (Údar), Nick Hornigold (Údar), Claire Hulme (Údar), Michelle Hutchinson (Údar), Carys Lippiatt (Údar), Tobias Livingstone (Údar), Roberta Longo (Údar), Matthew Potton (Údar), Stephanie Roberts (Údar), Sheryl Sim (Údar), Sebastian Trainor (Údar), Matthew Welberry Smith (Údar), James Neuberger (Údar), Douglas Thorburn (Údar), Paul Richardson (Údar), John Christie (Údar), Neil Sheerin (Údar), William McKane (Údar), Paul Gibbs (Údar), Anusha Edwards (Údar), Naeem Soomro (Údar), Adebanji Adeyoju (Údar), Grant D Stewart (Údar), David Hrouda (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: NIHR Journals Library, 2018-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Protein biomarkers with associations with the activity and outcomes of diseases are being identified by modern proteomic technologies. They may be simple, accessible, cheap and safe tests that can inform diagnosis, prognosis, treatment selection, monitoring of disease activity and therap...